These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2373131)

  • 21. A comparison of once daily atenolol and metoprolol SA in mild to moderate hypertension.
    Morley CA; Cavalcanti C; Perrins EJ; Sutton R
    Br J Clin Pharmacol; 1983 Jun; 15(6):715-7. PubMed ID: 6347229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic and pharmacodynamic evaluation of metoprolol controlled release (CR/ZOK) 50 mg in young subjects.
    Wieselgren I; Lundborg P; Sandberg A; Olofsson B; Bergstrand R
    J Clin Pharmacol; 1990 Feb; 30(S2):S28-32. PubMed ID: 2312776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmacodynamic and pharmacokinetic profiles of controlled-release formulations of felodipine and metoprolol in free and fixed combinations in elderly hypertensive patients.
    McLay JS; MacDonald TM; Hosie J; Elliott HL;
    Eur J Clin Pharmacol; 2000 Nov; 56(8):529-35. PubMed ID: 11151741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic and pharmacodynamic comparison of conventional and controlled release formulations of metoprolol [correction of motoprolol] in healthy Chinese subjects.
    Lee YT; Liau CS; Wong EC; Chen WJ; Chen MF; Chen CC
    Cardiovasc Drugs Ther; 1989 Aug; 3(4):529-33. PubMed ID: 2488104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No difference in general well-being during antihypertensive treatment with atenolol or metoprolol CR.
    Dahlöf C; Almkvist G; Dimenäs E; Jern S; Johansson B; Larsson C; Lorentzon S; Nilsson D; Nygaard-Pedersen L
    Ann Clin Res; 1988; 20 Suppl 48():42-50. PubMed ID: 3250317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: a comparison with conventional tablets.
    Sandberg A; Blomqvist I; Jonsson UE; Lundborg P
    Eur J Clin Pharmacol; 1988; 33 Suppl():S9-14. PubMed ID: 3371395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of controlled-release metoprolol on blood pressure and exercise heart rate in hypertension: a comparison with conventional tablets.
    Rydén L; Kristensson BE; Westergren G
    Eur J Clin Pharmacol; 1988; 33 Suppl():S33-7. PubMed ID: 3371392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aiming for steady 24-hour plasma concentrations: a comparison of two calcium antagonist and beta-blocker combinations.
    Eriksson M; Nyberg G; Lidman K; Olofsson B; Bergstrand R
    Blood Press Suppl; 1993; 1():16-21. PubMed ID: 7909705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pharmacokinetic and pharmacodynamic comparison of immediate-release metoprolol and extended-release metoprolol CR/XL in patients with suspected acute myocardial infarction: a randomized, open-label study.
    Karlson BW; Dellborg M; Gullestad L; Aberg J; Sugg J; Herlitz J
    Cardiology; 2014; 127(2):73-82. PubMed ID: 24247812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of 100 mg atenolol and 100 mg metoprolol once a day at rest and during exercise in hypertensives.
    Nilsson OR; Atterhög JH; Castenfors J; Jorfelt L; Karlberg BE; Thulin T; Tolagen K; Wettre S; Ohman KP
    Acta Med Scand; 1984; 216(3):301-7. PubMed ID: 6388253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic aspects of maximal exercise performance after slow release metoprolol and after atenolol.
    Folgering HT; Borm JF; van Haaren RH
    Eur J Clin Pharmacol; 1982 Oct; 23(4):283-8. PubMed ID: 7173299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerability and well-being with metoprolol in a controlled release (CR/ZOK) formulation: a review article.
    Dimenäs E; Dahlöf C
    J Clin Pharmacol; 1990 Feb; 30(S2):S92-7. PubMed ID: 2179287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of beta-blockade on heart rate variability in patients with coronary artery disease.
    Niemelä MJ; Airaksinen KE; Huikuri HV
    J Am Coll Cardiol; 1994 May; 23(6):1370-7. PubMed ID: 8176095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
    Ravid M; Lang R; Jutrin I
    Arch Intern Med; 1985 Jul; 145(7):1321-3. PubMed ID: 4015285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of two long-acting preparations of metoprolol with conventional metoprolol and atenolol in healthy men during chronic dosing.
    Freestone S; Silas JH; Lennard MS; Ramsay LE
    Br J Clin Pharmacol; 1982 Nov; 14(5):713-8. PubMed ID: 7138751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the beta 1-selectivity of conventional metoprolol and metoprolol CR during exercise in healthy volunteers.
    Akhlaghi S; Maxwell SR; Kendall MJ; Hughes B; Greenhaff P
    J Clin Pharm Ther; 1993 Aug; 18(4):259-66. PubMed ID: 8227233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of diltiazem on the pharmacokinetics of propranolol, metoprolol and atenolol.
    Tateishi T; Nakashima H; Shitou T; Kumagai Y; Ohashi K; Hosoda S; Ebihara A
    Eur J Clin Pharmacol; 1989; 36(1):67-70. PubMed ID: 2917591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of importance of central effects of atenolol and metoprolol measured by heart rate variability during mental performance tasks, physical exercise, and daily life in stable postinfarct patients.
    Tuininga YS; Crijns HJ; Brouwer J; van den Berg MP; Man in't Veld AJ; Mulder G; Lie KI
    Circulation; 1995 Dec; 92(12):3415-23. PubMed ID: 8521562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duration of beta-blockade with metoprolol and atenolol: influence of drug oxidation.
    Freestone S; Lennard MS; Silas JH; Ramsay LE
    Postgrad Med J; 1983; 59 Suppl 3():36-7. PubMed ID: 6647208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.